APLP1 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">APLP1 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>APLP1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>APLP1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=APLP1" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">37 edges</a></td>
</tr>
</table>
[APLP1](/genes/aplp1) (amyloid precursor-like protein 1) is a neuron-enriched member of the [APP](/entities/app-protein) protein family, together with [APP](/genes/app) and [APLP2](/proteins/aplp2-protein). APP family proteins are type-I transmembrane proteins that participate in synaptic organization, membrane trafficking, and activity-dependent signaling rather than serving only as amyloid precursors.[@schilling2017][@lee2020]
...APLP1 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">APLP1 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>APLP1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>APLP1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=APLP1" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">37 edges</a></td>
</tr>
</table>
[APLP1](/genes/aplp1) (amyloid precursor-like protein 1) is a neuron-enriched member of the [APP](/entities/app-protein) protein family, together with [APP](/genes/app) and [APLP2](/proteins/aplp2-protein). APP family proteins are type-I transmembrane proteins that participate in synaptic organization, membrane trafficking, and activity-dependent signaling rather than serving only as amyloid precursors.[@schilling2017][@lee2020]
Unlike APP, APLP1 does not contain the [amyloid-beta](/proteins/amyloid-beta) sequence, but it shares extracellular adhesion modules and intracellular interaction motifs that support trans-synaptic signaling complexes.[@schilling2017][@lee2020] This makes APLP1 important for understanding which APP-family functions are physiological and which are specific to amyloidogenic processing.
Molecular Architecture and Synaptic Localization
APLP1 contains extracellular E1 and E2 domains, a single transmembrane segment, and a short intracellular tail with conserved motifs that recruit adaptor proteins involved in vesicle trafficking and scaffold assembly.[@lee2020][@von1997] Across postnatal development, APP-family proteins increase in parallel with synaptogenesis, consistent with a role in synaptic maturation and maintenance.[@schilling2017]
Experimental work in cultured [neurons](/entities/neurons) and coculture systems shows that APP-family proteins can promote synaptogenic activity through trans-cellular interactions. APLP1 shows particularly strong cell-surface retention relative to other family members, which may support stable synaptic adhesion interfaces.[@schilling2017]
Functional Role in Circuit Physiology
Mouse genetics indicate partial redundancy across APP-family proteins plus specific nonredundant effects for APLP1. Early double-knockout studies established that APP-family combinations are required for normal development and survival, revealing essential baseline functions that single knockouts can mask.[@von1997]
More targeted electrophysiology studies showed that APLP1 loss can reduce basal excitatory synaptic transmission and dendritic spine maintenance in aging brains, even when gross neuroanatomy is preserved.[@schilling2017] Complementary conditional triple-family models demonstrated that combined APP-family deficiency disrupts hippocampal excitability tuning and plasticity, supporting a systems-level role in learning-relevant circuit stability.[@lee2020]
Taken together, current evidence supports a model in which APLP1 contributes to:
- maintenance of mature excitatory synapses,
- stability of dendritic spine populations over aging,
- fine control of synaptic efficacy within hippocampal networks.[@schilling2017][@lee2020]
Relevance to Neurodegeneration
APLP1 is best interpreted as a contextual modulator of neurodegenerative vulnerability rather than a primary monogenic driver of major dementias. Its relevance comes from three mechanistic links:
Shared family biology with APP: APP-family trafficking and cleavage pathways are interdependent, so perturbations in family balance can alter synaptic resilience during disease stress.[@lee2020][@von1997]
Synaptic maintenance function: Loss of synaptic integrity is an early feature of [Alzheimer's disease](/diseases/alzheimers-disease), and proteins that maintain spine and transmission homeostasis are plausible modifiers of progression trajectories.[@schilling2017][@lee2020]
Therapy interpretation: Interventions that broadly change APP-family processing may have off-target consequences for physiological APLP1-dependent synaptic functions.[@schilling2017]Current literature does not support using APLP1 alone as a stand-alone clinical biomarker for diagnosis, but it remains biologically relevant when interpreting APP-family pathway interventions and synaptic phenotypes.
Experimental and Translational Priorities
Priority questions for APLP1-focused work include:
- determining whether human APLP1 expression patterns stratify synaptic resilience phenotypes in early-stage neurodegenerative syndromes,
- defining how APP-family stoichiometry shifts in disease-specific cell types (pyramidal neurons, interneurons, and vulnerable projection populations),
- testing whether APP-processing therapies preserve or impair APLP1-supported synaptic adhesion under chronic treatment exposure.[@schilling2017][@lee2020]
These studies are most useful when embedded in integrated APP-family analyses rather than single-protein readouts.
See Also
- [APP Protein](/proteins/app)
- [APLP2 Protein](/proteins/aplp2-protein)
- [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
External Links
- [UniProt: APLP1 (Q15804)](https://www.uniprot.org/uniprotkb/Q15804/entry)
- [NCBI Gene: APLP1](https://www.ncbi.nlm.nih.gov/gene/333)
References
[Schilling S, Mehr A, Ludewig S, et al, APLP1 Is a Synaptic Cell Adhesion Molecule, Supporting Maintenance of Dendritic Spines and Basal Synaptic Transmission (2017)](https://pubmed.ncbi.nlm.nih.gov/28450540/)
[Lee SH, Kang J, Ho A, et al, APP Family Regulates Neuronal Excitability and Synaptic Plasticity but Not Neuronal Survival (2020)](https://pubmed.ncbi.nlm.nih.gov/32891188/)
[von Koch CS, Zheng H, Chen H, et al, Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members (1997)](https://pubmed.ncbi.nlm.nih.gov/11050115/)